LungLife AI Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.3%.

Top 17 shareholders own 75.87% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.5%	Simon Raab	4,148,293	€449.3k	0%	no data
12.7%	Unicorn Asset Management Ltd.	3,907,142	€423.1k	0%	0.06%
8.06%	Mount Sinai School Of Medicine, Endowment Arm	2,469,842	€267.5k	0%	0.13%
6.42%	Octopus Investments Limited	1,968,750	€213.2k	0%	0.01%
5.46%	Syno Capital	1,673,668	€181.3k	0%	no data
4.99%	Frederick Gluck	1,530,596	€165.8k	0%	no data
4.65%	Stifel Asset Management Corp.	1,424,784	€154.3k	0%	no data
4.55%	Investec Wealth & Investment Limited	1,394,839	€151.1k	0%	no data
4.4%	Bohai Ferry Group Co., Ltd.	1,347,653	€145.9k	0%	no data
4.14%	Lombard Odier	1,268,363	€137.4k	0%	no data
3.11%	Huateng Ma	954,048	€103.3k	0%	no data
2.73%	Killik Asset Management	836,964	€90.6k	0%	0.01%
0.71%	SVM Asset Management Limited	218,750	€23.7k	0%	0.01%
0.14%	Roy Davis	42,775	€4.6k	0%	no data
0.086%	David Anderson	26,408	€2.9k	0%	no data
0.086%	Paul Pagano	26,408	€2.9k	0%	no data
0.065%	Andrew Boteler	19,966	€2.2k	0%	no data